赛络通反复给药对大鼠CYP450活性的影响
赛络通(SLT)是由人参、银杏和西红花提取物组成的中药复方,初步临床试验和动物实验显示其可改善血管性痴呆(VD)患者的认知功能。本研究采用鸡尾酒探针法评估SLT反复给药对大鼠主要药物代谢CYP450酶活性的影响,结果显示SLT诱导CYP1A2和CYP2C11,抑制CYP3A1/2,对CYP2C6和CYP2D2无影响。
要点
- SLT反复给药可诱导大鼠CYP1A2,使AUC对氧咖啡因/AUC咖啡因比值增至144%。
- SLT和银杏组对氯沙坦代谢能力分别提高31%和25%,提示弱诱导CYP2C11。
- SLT抑制CYP3A1/2,使1-羟基咪达唑仑/咪达唑仑AUC比值降低39%,并延长咪达唑仑半衰期。
核心结论
- SLT反复给药可诱导大鼠CYP1A2和CYP2C11,抑制CYP3A1/2,对CYP2C6和CYP2D2无影响,临床应关注草药-药物相互作用。
研究设计与样本
- 采用鸡尾酒探针法评估CYP450活性,大鼠经SLT、人参、银杏、西红花或水预处理2周后口服探针药物混合物,用在线SPE-LC-MS/MS测定血浆探针及代谢物浓度。
主要发现
- 与对照组相比,SLT组AUC对氧咖啡因/AUC咖啡因比值增至144%,该影响主要归因于人参组分。
- SLT组和银杏组对氯沙坦的代谢能力分别提高31%和25%,提示弱诱导CYP2C11。
- SLT组1-羟基咪达唑仑/咪达唑仑AUC比值降低39%,咪达唑仑半衰期明显延长,全身暴露显著降低,提示CYP3A1/2抑制可能继发于肠道吸收层面的相互作用。
- 奥美拉唑和右美沙芬探针分析显示,所有处理组对CYP2C6和CYP2D2均无影响。
- SLT对CYP3A的抑制可能由人参和银杏协同作用所致。
临床怎么用
- 临床使用SLT时应考虑其与CYP1A2、CYP2C11和CYP3A1/2底物药物的潜在相互作用。
局限性
- 本研究为大鼠动物实验,结果外推至人体需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sailuotong (SLT) is a standard Chinese preparation made from extracts of Panax ginseng (ginseng), Ginkgo biloba (ginkgo), and Crocus sativus (saffron). Preliminary clinical trials and animal experiments have demonstrated that SLT could improve cognition of vascular dementia (VD). PURPOSE: To avoid incident drug-drug interaction which is easily encountered in patients of VD, the potential influence of SLT on main drug-metabolic cytochromes P450 enzymes (CYP450) was investigated. METHOD: A "cocktail probes" approach was employed to evaluate the activities of CYP450. A rapid and selective analysis method was developed to examine 5 CYP probe drugs and their specific metabolites in plasma by using online SPE followed by a single LC-MS/MS run. After pretreatment for 2 weeks with SLT, ginseng, gingko, saffron or water (control), a cocktail solution containing caffeine, losartan, omeprazole, dextromethorphan and midazolam was given to rats orally. The plasma was obtained at different time intervals and then measured for the concentration of probes and their metabolites using developed SPE-LC-MS/MS method. Activity of five isozymes was estimated by comparing plasma pharmacokinetics of substrates and their metabolites (caffeine/paraxanthine for CYP1A2, losartan/E-3174 for CYP2C11, omeprazole/5-hydroxyl omeprazole for CYP2C6, dextromethorphan/dextrophan for CYP2D2 and midazolam/1-hydroxyl midazolam for CYP3A1/2) between control and drug treatment groups. RESULT: Compared with control group, repeated administration of SLT induced CYP1A2 by enhancing AUC paraxanthine / AUC caffeine to144%. The influence is attributed to its herbal component of ginseng to a large extent. Meanwhile, metabolic ability towards losartan was significantly elevated in SLT and gingko group by 31% and 25% respectively, indicating weak induction of CYP2C11 in rats. The analysis on probes of omeprazole and dextromethorphan showed a lack of influence on CYP 2C6 and CYP2D2 in all treated groups. In terms of CYP3A1/2, SLT decreased AUC ratio of 1-hydroxyl midazolam to midazolam by 39% and extended the half-life of midazolam apparently. Besides, significantly decreased systematic exposure of midazolam suggested the inhibition on metabolism of CYP3A1/2 is likely secondary to the interaction on absorption at intestinal level. The inhibition of SLT on CYP3A was likely attributed to ginseng and gingko cooperatively. CONCLUSION: Further observation on herb-drug interaction should be considered during clinical application of SLT.
引用
- Zhang Y, Miao L, Lin L, et al. Repeated administration of Sailuotong, a fixed combination of Panax ginseng, Ginkgo biloba, and Crocus sativus extracts for vascular dementia, alters CYP450 activities in rats. Phytomedicine. 2017. PMID: 29425645. doi:10.1016/j.phymed.2017.02.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。